Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy

Fig. 1

The phenotypes of PMN-MDSCs and M-MDSCs. In mice, PMN-MDSCs are defined as CD11b+Ly6G+Ly6Clo, and M-MDSCs are defined as CD11b+Ly6G−Ly6Chi. Human PMN-MDSCs are defined as CD11b + CD14− CD15+ or CD11b+ CD14 - CD66b+, and human M-MDSCs are defined as CD11b+ CD14+ HLA-DR−/low CD15−. In addition, several other markers have been associated with the MDSCs phenotype, such as CD49d, LOX1 and IL-4Rα

Back to article page